The Latin America, Middle East and Africa Intragastric Balloon Market would witness market growth of 13.4% CAGR during the forecast period (2020-2026). Increased use of minimally invasive techniques over the forecast period would boost market growth. Intragastric balloons are orally introduced and do not require any incision accompanied by balloon inflation with a saline solution or gas. Growing approval of the intragastric balloon system will serve as useful non-surgical treatment options for the treatment of diseases linked to obesity and weight.
Saline-filled intragastric balloon business accounted for a substantial market share. Ability to reduce weight more efficiently and rapidly by methylene blue dye to detect silicone balloon deflation and will benefit the adoption rate. The American Society of Gastrointestinal Endoscopy indicates that most patients undergoing saline-filled intragastric balloon treatment tend to lose around a quarter of their body mass. As a result, the above-mentioned factors will foster future segmental growth.
The gas-filled balloon market is anticipated to rise at an exponential growth rate over the forecast period. The segmental growth is attributed to three layers of bacteria-resistant material, which reduces the chances of undesirable effects and improves the comfort of patients in the event of deflation. In addition, the balloon's quality to improve patient compliance in spontaneous deflation removal and avoidance will stimulate market growth rate.
Based on Administration, the market is segmented into Endoscopy and Pill Form. Based on Type, the market is segmented into Single, Dual and Triple. Based on Filling Material, the market is segmented into Gas Filled and saline Filled. Based on End Use, the market is segmented into Clinics, Hospitals and Ambulatory Surgical Centers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: Intragastric Balloon Market in LAMEA is expected to register a CAGR of 13.4% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sientra, Inc. (Silimed, Inc.), Apollo Endosurgery, Inc., Obalon Therapeutics, Inc., ReShape Lifesciences Inc., Allurion Technologies, Inc., Helioscopie SA (Sante Actions Group), Districlass Medical SA, Spatz FGIA, Inc., Duomed Group (Life Partners Europe), Medsil.
Market Segmentation:
By Administration
By Type
By Filling Material
By End Use
By Country
Companies Profiled
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 